Menu

莫努匹韦的安全性和疗效怎么样?国内哪里能买到莫努匹韦?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Monupivir is a drug jointly developed by the American pharmaceutical company Merck and the biotechnology company Ridgeback Biotherapeutics. It can treat COVID-19 and reduce the risk of hospitalization or death in early-stage COVID-19 patients by about 50%. It is an RNA polymerase inhibitor and a small molecule drug targeting coronavirus.

So, what are the details on the safety and efficacy of monoprevir?

According to data from the Phase III MOVe-OUT study, compared with monopivir and placebo, the hospitalization/death ratio within 29 days in the placebo control group was 14.1% (53/377), and the hospitalization/death ratio within 29 days in the treatment group was 7.3% (28/385). The risk of hospitalization and death in the monopivir treatment group was reduced by 50%, and no patient deaths were reported within 29 days. Eight patient deaths were reported in the placebo control group. In terms of safety, the incidence of any adverse events in the monupivir group was similar to that in the placebo group (35% vs 40%) and the proportion of patients discontinuing treatment due to adverse events was lower in the monupivir group (1.3% vs 3.4%). Diarrhea, nausea, dizziness and headache are common adverse reactions in patients, and the safety is tolerable.

So, where can I buy Monupivir in China?

Monupivir is currently not on the market in China. Patients cannot buy this drug in domestic hospital pharmacies and need to go abroad to purchase it, which is expensive. It is recommended that patients obtain Monupivir through domestic professional overseas medical service agencies such as Medical Companion Travel. Direct mail from the pharmaceutical factory is very cost-effective and can ensure that the drug is genuine. Medical Companion Travel has cooperated with many patients in China and can help patients obtain overseas versions of drugs and sign drug purchase guarantee contracts so that patients can purchase drugs with confidence. It is recommended to consult the customer service staff of Medical Companion for specific drug prices and drug purchase procedures.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。